Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) [Phase 2]
Phase 2 clinical trial update for JNJ-95475939 in adults with moderate to severe atopic dermatitis. The study is currently active but not re…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD [Phase 1]
Phase 1 trial of Soquelitinib in adults with moderate-to-severe atopic dermatitis shows safety and tolerability with preliminary signs of ef…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
This document reports the completion status of a Phase 2 trial evaluating ATI-2138 in adults with moderate to severe atopic dermatitis.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial update on dupilumab evaluating its effect on anxiety and depression symptoms in patients with moderate-to-severe atopic derma…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China
An ongoing observational study in China is evaluating real-world use of Upadacitinib tablets in adolescents and adults with moderate-to-seve…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of IBI356 in participants with moderate-to-severe atopic dermatitis and is cu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) [Phase 1]
An ongoing Phase 1 clinical trial sponsored by NIAID is evaluating a microbiome-based therapy for atopic dermatitis (TIME-2) and is currentl…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: MYCobiome Analysis in Atopic Dermatitis With Head and Neck Involvement
The trial examining MYCobiome analysis in atopic dermatitis with head and neck involvement has completed.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 multicenter randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of CMS-D001 in adults with modera…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients [Phase 4]
Phase 4 clinical trial investigating whether decolonizing Staphylococcus aureus skin reduces disease severity in patients with atopic dermat…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234 [Phase 1]
Phase 1a/1b dose-escalation study of ARQ-234 in adults with atopic dermatitis and eczema is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema [Phase 4]
Phase 4 trial update evaluating the efficacy of crisaborole 2% cream versus placebo for mild-to-moderate atopic dermatitis (atopic eczema), …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease [Phase 1]
Phase 1 study of S-4321 in autoimmune and immune-mediated diseases; the trial status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus [Phase 1]
This Phase 1 trial update reports on the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy volunteers and patients with ato…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study of SHR-1819 injection in adults with moderate to severe atopic dermatitis has completed, with a status update provided.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD [Phase 2]
A Phase 2 clinical trial evaluating Soquelitinib for moderate-to-severe Atopic Dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
A completed post-authorization safety study in North America evaluating pregnancy and infant outcomes after dupilumab exposure during pregna…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
A clinical trial update shows a study evaluating tralokinumab for moderate-to-severe atopic dermatitis with genital involvement is currently…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete [NA]
This document is a clinical trial registration for BioAmicus Complete, a randomized, blinded, placebo-controlled study sponsored by NovoNatu…
-
EMA approval · 2026-03-02EMA Authorised: Nemluvio (nemolizumab) — Galderma International
The European Medicines Agency has authorised nemolizumab (Nemluvio) for use in atopic dermatitis and prurigo, marking a new monoclonal antib…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Bodewell Products for the Treatment of Atopic Dermatitis [Phase 4]
Phase 4 clinical trial update for Bodewell Products in Atopic Dermatitis; the study led by the University of Alabama at Birmingham is curren…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis [Phase 4]
A Phase 4 trial is comparing the safety and effectiveness of Crisaborole Ointment 2% versus Tacrolimus Ointment 0.1% for topical treatment o…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients [Phase 1]
Phase 1a/1b study of TRB-061 in healthy participants and adults with moderate-to-severe atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Seal, Stopping Eczema and Allergy Study [Phase 2]
Phase 2 eczema and allergy trial is being stopped. The current status is ACTIVE_NOT_RECRUITING, indicating no recruitment at this time.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
An update on a clinical trial evaluating adverse events and changes in disease state for oral upadacitinib in adolescents aged 12 to <18 wit…